Crohn's Disease and Colitis Trial, Recruiting NCT05421455 Sponsor: Zhu Weiming Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT05421455
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have symptoms of a blocked or narrowed intestine (such as pain, bloating, or difficulty passing stool)
  • You have been confirmed to have a narrowing (stricture) in your intestine
  • Standard medications have not been enough to bring your condition under control
  • There is evidence that your bowel is currently inflamed and active
  • A procedure called endoscopic balloon dilation (a non-surgical way to widen the narrowing) is not a suitable option for you (confirm with trial site)
  • You are willing and able to give written consent to take part

Who may not be able to join:

  • Standard medical treatments for your intestinal blockage have not worked (confirm with trial site)
  • You have a completely blocked intestine
  • You have a medical reason why you cannot take biologic medications (a type of targeted therapy)
  • Your condition involves tunnels or holes forming through the bowel wall (known as penetrating disease)
  • You have a very short small bowel
  • There is any suspicion that you may have a bowel tumour
  • You do not have a confirmed narrowing in your intestine
  • You have another serious illness affecting another part of your body
  • Your blockage symptoms have continued even after trying more than two different biologic medications
  • Your condition has already been successfully managed with standard medications
  • You are currently taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86025-80860036

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhu Weiming
Registry
ClinicalTrials.gov
Start date
9 June 2022
Est. completion
1 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

clinical remmision rate within 1 year

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov